equishield ehv émuls. inj. i.m. flac.
dechra regulatory b.v. - herpèsvirus equin 1, inactivé - emulsion injectable - herpèsvirus equin - equine rhinopneumonitis virus - cheval
roaccutane 5 mg, capsule molle
roche - isotrétinoïne - capsule - 5 mg - composition pour une capsule > isotrétinoïne : 5 mg - rétinoïdes dans le traitement de l'acné
roaccutane 10 mg, capsule molle
roche - isotrétinoïne - capsule - 10 mg - composition pour une capsule > isotrétinoïne : 10 mg - rétinoïdes dans le traitement de l'acné
balmed hermal f médical engagement positif
almirall ag - arachidis oleum, paraffinum perliquidum - médical engagement positif - arachidis oleum 464.5 mg, paraffinum perliquidum 470 mg, macrogoli 4 aether laurilicus, isopropylis palmitas, poly(ethylenglycoli)/poly(propylenglycoli) 120/10-trimethylolpropylis trioleas, macrogoli 2 aether laurilicus, aqua, acidum citricum monohydricum, propylenglycolum, e 321 0.1 mg, e 304, aromatica cum limonenum q.s. et linaloolum q.s., ad solutionem pro 1 g. - sécheresse de la peau sensible, soutien, traitement de diverses maladies de la peau - synthetika
terzolin shampooing
spirig healthcare ag - ketoconazolum - shampooing - ketoconazolum 10 mg, hypromellosum, natrii laureth-2-sulfas, acidum citricum, natrii cocoylsarcosinas, cocoylis monoethanolamidum, ethylenglycoli distearas, tetranatrii edetas, e 321 1 mg, polyquaternium-7, e 211 0.04 mg, alcohol benzylicus 12.5 mg, e 133, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aromatica cum 3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-onum, benzylis benzoas, benzylis salicylas, lilialum, citralum, citronellolum, cumarinum, eugenolum, geraniolum, hydroxycitronellalum, isoeugenolum, limonenum et linaloolum, aqua purificata q.s. ad solutionem pro 1 g. - antimykotikum/antiseborrhoikum - synthetika
utrogestan vaginal 300 mg caps. molle
besins healthcare sa-nv - progestérone 300 mg - capsule molle - 300 mg - progestérone 300 mg - progesterone
gynodian depot solution injectable i. m.
bayer (schweiz) ag - estradioli valeras, prasteroni heptanoas - solution injectable i. m. - estradioli valeras 4 mg, prasteroni heptanoas 200 mg, benzylis benzoas, huile de ricin virginale q.s. pour une solution au lieu de 1 ml. - oestrogensubstitutions thérapie de l'inapplicabilité de l'une par voie orale ou transdermique thérapie - synthetika
enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - néoplasmes du sein - agents antinéoplasiques - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.
isotretinoine eg labo 20 mg, capsule molle
eg labo - laboratoires eurogenerics - isotrétinoïne - capsule - 20 mg - composition pour une capsule > isotrétinoïne : 20 mg - preparations antiacneiques a usage systemique
isotretinoine eg labo 10 mg, capsule molle
eg labo - laboratoires eurogenerics - isotrétinoïne - capsule - 10 mg - composition pour une capsule > isotrétinoïne : 10 mg - preparations antiacneiques a usage systemique